China Resources Pharmaceutical Group Limited

HKEX:3320.HK

5.55 (HKD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016201520142013
Assets:
Current Assets:
Cash & Cash Equivalents 24,650.6724,118.06725,327.76517,723.42717,138.62716,633.30114,161.83313,960.19712,378.60613,417.62415,175.387
Short Term Investments 8,346.1728,404.25211,987.91234,613.8235,646.45928,023.5496,556.6423,648.8466,310.355,580.3221,756.644
Cash and Short Term Investments 59,266.38732,522.31937,315.67752,337.2522,785.08644,656.8520,718.47517,609.04318,688.95618,997.94616,932.031
Net Receivables 105,277.61102,615.19295,958.26866,449.6375,136.2847,258.81658,951.94848,273.97441,327.58537,109.17435,372.301
Inventory 31,875.48729,718.44629,687.99224,584.76122,332.37421,527.92321,406.29818,859.12115,251.98315,711.4812,198.122
Other Current Assets 87,425.9565,595.49824,980.163,737.21612,688.87616,831.28114,486.51910,692.62915,402.67313,566.6922,987.99
Total Current Assets 196,604.133170,451.455176,609.609147,108.857132,942.616127,266.224113,198.52393,802.41388,856.87784,277.19168,797.831
Non-Current Assets:
Property, Plant & Equipment, Net 27,939.55324,732.02125,531.73622,642.23822,104.51714,652.22814,737.65112,500.07712,578.25713,505.80212,887.323
Goodwill 21,454.2822,847.66724,901.5521,072.19219,306.4419,804.85420,544.61217,404.82116,394.50915,321.6614,892.86
Intangible Assets 8,039.72131,346.63434,033.6628,011.82525,355.6354,063.2294,163.1423,422.1523,546.4786,336.5595,962.106
Goodwill and Intangible Assets 29,494.00154,194.30158,935.2149,084.01744,662.07523,868.08324,707.75420,826.97319,940.98721,658.21920,854.966
Long Term Investments 12,593.44913,147.20811,055.85910,287.6177,944.5643,534.3252,535.2422,072.248589.525-4,737.803-672.391
Tax Assets 1,952.4841,606.2151,309.559969.852856.088621.419573.516448.305422.518513.445343.746
Other Non-Current Assets 3,111.792-22,844.782-24,879.663-20,720.821-18,484.847-621.419-573.516-448.305-422.5186,580.7482,611.592
Total Non-Current Assets 75,091.27970,834.96371,952.70162,262.90357,082.39742,054.63641,980.64735,399.29833,108.76937,520.41136,025.236
Total Assets 246,770.296241,286.418248,562.31209,371.76190,025.013176,184.2160,754.148133,985.514127,148.599121,797.602104,823.067
Liabilities & Equity:
Current Liabilities:
Account Payables 54,451.02148,711.22461,764.27638,511.313,039.22734,699.08819,766.24318,182.19917,516.76224,632.71219,317.49
Short Term Debt 46,223.58936,799.01539,600.20651,922.23543,442.92228,886.89927,935.61319,326.6720,378.04220,350.56120,161.622
Tax Payables 803.768747.029894.385671.127452.959603.263559.5491,139.4831,125.368887.135901.342
Deferred Revenue 03,960.6353,556.9512,477.7631,651.9041,711.938-45,313.001-33,443.705-34,757.4700
Other Current Liabilities 32,754.37750,061.88939,063.70929,037.22159,736.56113,276.39743,472.9932,336.28533,203.62419,602.0818,517.453
Total Current Liabilities 134,232.755136,319.157141,322.576122,619.655106,671.669103,358.36991,734.39570,984.63772,223.79665,472.48858,897.907
Non-Current Liabilities:
Long Term Debt 15,937.37210,984.5258,113.0912,981.77510,710.39710,149.6683,443.6526,384.76212,882.85316,912.28511,053.975
Deferred Revenue Non-Current 788.581867.753890.778651.442601.126674.869734.462697.136728.974737.253762.008
Deferred Tax Liabilities Non-Current 1,718.121,777.081,965.3341,668.8711,506.573881.272964.443938.447862.353815.55720.609
Other Non-Current Liabilities 1,118.6541,155.57916.6211,683.0013,061.1261,532.5221,704.4691,617.1251,467.4111,525.1221,460.483
Total Non-Current Liabilities 19,562.72713,917.17511,364.696,071.21913,170.39710,149.6683,443.6526,384.76212,882.85319,174.6613,276.466
Total Liabilities 153,795.482150,236.332152,687.266128,690.874119,842.066115,715.42897,616.97879,683.6687,303.03484,647.14872,174.373
Equity:
Preferred Stock 000007,649.13,508.5135,517.4533,077.2700
Common Stock 27,118.30427,241.28927,241.28927,241.28927,241.28927,241.28927,241.28927,241.28912,473.9212,473.924,629.424
Retained Earnings 32,076.21430,936.52527,732.53424,717.54622,121.01920,385.2518,801.4416,552.35813,730.94810,880.8728,234.932
Accumulated Other Comprehensive Income/Loss -8,592.748-8,618.395-3,992.336-5,489.009-8,650.96-7,649.1-3,508.513-5,517.453-3,077.27-3,876.333-3,928.682
Other Total Stockholders Equity 00664.41724,717.546664.41720,385.2518,801.4416,552.35813,730.94811,918.73217,287.513
Total Shareholders Equity 50,601.7749,559.41950,981.48746,469.82640,711.34839,313.02241,869.79937,620.34522,502.23520,516.31917,988.255
Total Equity 102,365.76690,182.33394,984.26680,029.44469,581.82160,468.77263,137.1754,301.85439,845.56537,150.45432,648.694
Total Liabilities & Shareholders Equity 271,695.411241,286.418248,562.31209,371.76190,025.013176,184.2160,754.148133,985.514127,148.599121,797.602104,823.067